SEC Form 4 · accession 0001562180-17-003382
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brenda S. Furlow
Officer — SVP - General Counsel
Period of report
Oct 26, 2017
Accepted (ET)
Oct 30, 2017 · 4:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 1,668 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Oct 26, 2017 | A | 1,724 | A | — | — | Common Stock | 1,724 | 1,724 | D |
| Stock Options (Right to buy)F2 | $125.05 | Oct 26, 2017 | A | 9,503 | A | — | Aug 9, 2024 | Common Stock | 9,503 | 9,503 | D |
| Stock Options (Right to buy)F3 | $125.05 | Oct 26, 2017 | A | 12,670 | A | — | Aug 9, 2024 | Common Stock | 12,670 | 12,670 | D |
| Restricted Stock UnitsF1,F4 | — | holding | — | — | — | — | — | Common Stock | 1,200 | 1,200 | D |
| Restricted Stock UnitsF1,F5 | — | holding | — | — | — | — | — | Common Stock | 1,759 | 1,759 | D |
| Stock Option (Right to Buy)F6 | $108.49 | holding | — | — | — | — | Aug 7, 2022 | Common Stock | 10,000 | 10,000 | D |
| Stock Option (Right to Buy)F4 | $108.49 | holding | — | — | — | — | Aug 7, 2022 | Common Stock | 7,500 | 7,500 | D |
| Stock Option (Right to Buy)F7 | $94.35 | holding | — | — | — | — | Aug 12, 2021 | Common Stock | 15,000 | 15,000 | D |
| Stock Options (Right to buy)F8 | $106.59 | holding | — | — | — | — | Aug 18, 2023 | Common Stock | 14,476 | 14,476 | D |
| Stock Options (Right to buy)F5 | $106.59 | holding | — | — | — | — | Aug 18, 2023 | Common Stock | 10,857 | 10,857 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- F2Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F3Vest 3,167 shares each on 8/9/2018, 8/9/2019 and 3,168 shares each on 8/9/2020, 8/9/2021.
- F4Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F5Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F62,500 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
- F73,750 shares vest on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18.
- F8Vests 3,619 shares on each of 8/18/17, 8/18/18, 8/18/19 and 8/18/20.